Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
affitope ad02 (4 trials)
affitope ad01 (1 trial)
affitope ad03 (1 trial)
affitope ad04 (1 trial)
affitope ad06 (1 trial)
affitope pd01a (5 trials)
affitope pd03a (2 trials)
aluminum hydroxide (Gaviscon) (5 trials)
ath03 (1 trial)
Alzheimer Disease (Phase 2)
Atrophy (Phase 1)
Hypercholesterolemia (Phase 1)
Multiple System Atrophy (Phase 1)
Neurodegenerative Diseases (Phase 1)
Parkinson Disease (Phase 1)
Shy-Drager Syndrome (Phase 1)
Trials (14 total)
Trial APIs (9 total)